Literature DB >> 18716683

Burkholderia pseudomallei infection in a cystic fibrosis patient from the Caribbean: a case report.

Dimas Mateos Corral1, Allan L Coates, Yvonne C W Yau, Raymond Tellier, Mindy Glass, Steven M Jones, Valerie J Waters.   

Abstract

Burkholderia pseudomallei is a pathogen identified with increasing frequency in the respiratory tracts of cystic fibrosis (CF) patients from endemic areas such as Southeast Asia and northern Australia. The following report describes the first known reported case in a CF patient from the Caribbean attending a North American CF clinic.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18716683      PMCID： PMC2679542          DOI： 10.1155/2008/290412

Source DB:  PubMed          Journal:  Can Respir J        ISSN： 1198-2241            Impact factor:   2.409


  12 in total

1.  Laboratory exposure to Burkholderia pseudomallei--Los Angeles, California, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-10-29       Impact factor: 17.586

2.  Cystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem?

Authors:  David James Holland; Alison Wesley; Dragana Drinkovic; Bart J Currie
Journal:  Clin Infect Dis       Date:  2002-11-19       Impact factor: 9.079

3.  Laboratory acquired melioidosis.

Authors:  R N Green; P G Tuffnell
Journal:  Am J Med       Date:  1968-04       Impact factor: 4.965

Review 4.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

5.  Laboratory-acquired infection with Pseudomonas pseudomallei (melioidosis).

Authors:  W F Schlech; J B Turchik; R E Westlake; G C Klein; J D Band; R E Weaver
Journal:  N Engl J Med       Date:  1981-11-05       Impact factor: 91.245

6.  Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: a case report.

Authors:  P Visca; G Cazzola; A Petrucca; C Braggion
Journal:  Clin Infect Dis       Date:  2000-12-11       Impact factor: 9.079

7.  Chronic melioidosis in a patient with cystic fibrosis.

Authors:  T Schülin; I Steinmetz
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

8.  Melioidosis and safety in the clinical laboratory.

Authors:  L R Ashdown
Journal:  J Hosp Infect       Date:  1992-08       Impact factor: 3.926

9.  Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei.

Authors:  Jay E Gee; Claudio T Sacchi; Mindy B Glass; Barun K De; Robbin S Weyant; Paul N Levett; Anne M Whitney; Alex R Hoffmaster; Tanja Popovic
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

10.  Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis.

Authors:  M R O'Carroll; T J Kidd; C Coulter; H V Smith; B R Rose; C Harbour; S C Bell
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139
View more
  15 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  The Brief Case: A Traveler's Tale-Burkholderia pseudomallei Infection in a Cystic Fibrosis Patient.

Authors:  I T Hettiarachchi; J Duckers; D Lau; R Dhillon
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

Review 3.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

4.  Whole-Genome Sequences of Five Burkholderia pseudomallei Isolates from Australian Cystic Fibrosis Patients.

Authors:  Linda T Viberg; Erin P Price; Timothy J Kidd; Scott C Bell; Bart J Currie; Derek S Sarovich
Journal:  Genome Announc       Date:  2015-04-16

Review 5.  Melioidosis in Trinidad and Tobago.

Authors:  Catherine Hogan; Amanda Wilmer; Mazen Badawi; Linda Hoang; Michael Chapman; Natasha Press; Kym Antonation; Cindi Corbett; Marc Romney; Melanie Murray
Journal:  Emerg Infect Dis       Date:  2015-05       Impact factor: 6.883

6.  Editorial commentary: melioidosis in Puerto Rico: the iceberg slowly emerges.

Authors:  David A B Dance
Journal:  Clin Infect Dis       Date:  2014-09-30       Impact factor: 9.079

7.  The Identification and Differentiation between Burkholderia mallei and Burkholderia pseudomallei Using One Gene Pyrosequencing.

Authors:  Damian H Gilling; Vicki Ann Luna; Cori Pflugradt
Journal:  Int Sch Res Notices       Date:  2014-10-02

8.  Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell Matrix-assisted Laser Desorption/Ionisation mass spectrometric typing.

Authors:  Axel Karger; Rüdiger Stock; Mario Ziller; Mandy C Elschner; Barbara Bettin; Falk Melzer; Thomas Maier; Markus Kostrzewa; Holger C Scholz; Heinrich Neubauer; Herbert Tomaso
Journal:  BMC Microbiol       Date:  2012-10-10       Impact factor: 3.605

9.  Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils.

Authors:  Michael E Woodman; Randall G Worth; R Mark Wooten
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

10.  An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosis.

Authors:  James B Geake; David W Reid; Bart J Currie; Scott C Bell; Rowland Bright-Thomas; Jane Dewar; Steve Holden; Nicholas Simmonds; Khin Gyi; Dervla Kenna; Valerie Waters; Mary Jackson; Brian O'Sullivan; Giovanni Taccetti; John Kolbe; Mark O'Carroll; Dee Campbell; Mirjana Jaksic; Naghmeh Radhakrishna; Timothy J Kidd; William Flight
Journal:  BMC Pulm Med       Date:  2015-10-09       Impact factor: 3.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.